Genetics of Prostate Cancer (PDQ®)–Health Professional Version
SECTIONS
- Executive Summary
- Introduction
- Identifying Genes and Inherited Variants Associated With Prostate Cancer Risk
- Genes With Potential Clinical Relevance in Prostate Cancer Risk
- Interventions in Familial Prostate Cancer
- Prostate Cancer Risk Assessment
- Psychosocial Issues in Familial Prostate Cancer
- Changes to This Summary (01/20/2017)
- About This PDQ Summary
- View All Sections
Changes to This Summary (01/20/2017)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.
Updated statistics with estimated new prostate cancer cases and deaths for 2017 (cited American Cancer Society as reference 1).
Updated statistics with age-specific probabilities of being diagnosed with prostate cancer in 2017.
Revised text to state that because a man’s lifetime risk of prostate cancer is one in eight (cited American Cancer Society as reference 4), it is possible that families under study have men with both inherited and sporadic prostate cancer.
Revised text to state that prostate cancer will affect an estimated one in eight American men during their lifetime (cited American Cancer Society as reference 3).
This summary is written and maintained by the PDQ Cancer Genetics Editorial Board, which is editorially independent of NCI. The summary reflects an independent review of the literature and does not represent a policy statement of NCI or NIH. More information about summary policies and the role of the PDQ Editorial Boards in maintaining the PDQ summaries can be found on the About This PDQ Summary and PDQ® - NCI's Comprehensive Cancer Database pages.
No hay comentarios:
Publicar un comentario